Maria Nowacka

475 total citations
28 papers, 366 citations indexed

About

Maria Nowacka is a scholar working on Clinical Biochemistry, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Maria Nowacka has authored 28 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Clinical Biochemistry, 9 papers in Physiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Maria Nowacka's work include Metabolism and Genetic Disorders (18 papers), Diet and metabolism studies (9 papers) and Mitochondrial Function and Pathology (4 papers). Maria Nowacka is often cited by papers focused on Metabolism and Genetic Disorders (18 papers), Diet and metabolism studies (9 papers) and Mitochondrial Function and Pathology (4 papers). Maria Nowacka collaborates with scholars based in Poland, United Kingdom and Germany. Maria Nowacka's co-authors include Kirsten Ahring, K Motzfeldt, Anita MacDonald, Anna Maria Lammardo, Katharina Dokoupil, Amaya Bélanger‐Quintana, Andrzej Milanowski, Hülya Gökmen-Özel, Maria Giżewska and M. van Rijn and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antioxidants and Redox Signaling and Quality of Life Research.

In The Last Decade

Maria Nowacka

24 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Nowacka Poland 9 322 202 169 96 64 28 366
Ann Wessel United States 11 274 0.9× 141 0.7× 119 0.7× 78 0.8× 56 0.9× 18 309
P. J. Lee United Kingdom 13 170 0.5× 186 0.9× 109 0.6× 156 1.6× 48 0.8× 20 366
Verónica Cornejo Chile 11 241 0.7× 81 0.4× 184 1.1× 105 1.1× 67 1.0× 34 351
Adrya Stembridge United States 5 287 0.9× 110 0.5× 155 0.9× 60 0.6× 44 0.7× 8 323
M. Lilburn United Kingdom 12 179 0.6× 129 0.6× 111 0.7× 91 0.9× 50 0.8× 15 297
Sabrina Paci Italy 12 196 0.6× 169 0.8× 148 0.9× 132 1.4× 44 0.7× 31 404
Alena Gerlinde Thiele Germany 9 204 0.6× 140 0.7× 114 0.7× 46 0.5× 36 0.6× 16 217
A Burlina Italy 7 263 0.8× 79 0.4× 212 1.3× 92 1.0× 55 0.9× 17 374
Ljerka Cvitanović-Šojat Croatia 8 273 0.8× 60 0.3× 229 1.4× 57 0.6× 93 1.5× 16 377
Steven Yannicelli United States 16 456 1.4× 248 1.2× 209 1.2× 126 1.3× 79 1.2× 28 525

Countries citing papers authored by Maria Nowacka

Since Specialization
Citations

This map shows the geographic impact of Maria Nowacka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Nowacka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Nowacka more than expected).

Fields of papers citing papers by Maria Nowacka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Nowacka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Nowacka. The network helps show where Maria Nowacka may publish in the future.

Co-authorship network of co-authors of Maria Nowacka

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Nowacka. A scholar is included among the top collaborators of Maria Nowacka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Nowacka. Maria Nowacka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hozyasz, Kamil K., et al.. (2018). Prevention of maternal phenylketonuria. Dietary management in the preconception period and during pregnancy. Pediatria i Medycyna Rodzinna. 14(1). 47–53. 3 indexed citations
3.
Nowacka, Maria. (2018). Leibniz jako prekursor zdrowia publicznego. 9(3). 137–137.
4.
Mikołuć, Bożena, Jolanta Sawicka-Powierza, Bożena Didycz, et al.. (2017). Phenylketonuria patients’ and their parents’ knowledge and attitudes to the daily diet - multi-centre study. Nutrition & Metabolism. 14(1). 57–57. 29 indexed citations
5.
Mikołuć, Bożena, Bożena Didycz, Agata Lange, et al.. (2016). Phenylketonuria patients’ and their parents’ acceptance of the disease: multi-centre study. Quality of Life Research. 25(11). 2967–2975. 8 indexed citations
6.
Zielińska, Magdalena, et al.. (2016). [High plasma folate in patients with phenylketonuria].. PubMed. 40(238). 223–9.
7.
Szymańska, Krystyna, Katarzyna Kuśmierska, Maria Nowacka, Jolanta Sykut‐Cegielska, & Urszula Demkow. (2014). Phenotypic features of children with neurodevelopmental diseases in relation to biogenic amines. Respiratory Physiology & Neurobiology. 209. 124–132. 1 indexed citations
8.
Burton, Barbara K., Maria Nowacka, Julia B. Hennermann, et al.. (2011). Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: Results of a phase 3b study. Molecular Genetics and Metabolism. 103(4). 315–322. 28 indexed citations
9.
Bélanger‐Quintana, Amaya, Katharina Dokoupil, Hülya Gökmen-Özel, et al.. (2011). Diet in phenylketonuria: A snapshot of special dietary costs and reimbursement systems in 10 international centers. Molecular Genetics and Metabolism. 105(3). 390–394. 31 indexed citations
10.
Mikołuć, Bożena, Joanna Karpińska, Bożena Didycz, et al.. (2011). Impact of Lipophilic Antioxidants and Level of Antibodies Against Oxidized Low-Density Lipoprotein in Polish Children with Phenylketonuria. Antioxidants and Redox Signaling. 16(2). 179–182. 8 indexed citations
11.
Ahring, Kirsten, Amaya Bélanger-Quintana, Katharina Dokoupil, et al.. (2010). Blood phenylalanine control in phenylketonuria: a survey of 10 European centres. European Journal of Clinical Nutrition. 65(2). 275–278. 58 indexed citations
12.
Ahring, Kirsten, Amaya Bélanger‐Quintana, Katharina Dokoupil, et al.. (2009). Dietary management practices in phenylketonuria across European centres. Clinical Nutrition. 28(3). 231–236. 71 indexed citations
13.
Ambroszkiewicz, Jadwiga, Joanna Gajewska, Magdalena Chełchowska, et al.. (2008). [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria].. PubMed. 25(145). 57–60. 6 indexed citations
14.
Nowacka, Maria, et al.. (2006). "Autonomia pacjenta jako problem moralny", Maria Nowacka, Białystok 2005 : [recenzja] / Teresa Ostrowska.. Kwartalnik Historii Nauki i Techniki. 51. 1 indexed citations
15.
Bik-Multanowski, Mirosław, Maria Nowacka, Agata Lange, et al.. (2005). Use of handheld computers for assessment of prefrontal cortex function in patients with phenylketonuria. Molecular Genetics and Metabolism. 86. 142–144. 1 indexed citations
16.
Nowacka, Maria. (2004). Utylitarystyczne rozumienie osoby ludzkiej. SHILAP Revista de lepidopterología. 6. 13–25. 1 indexed citations
17.
Żekanowski, Cezary, et al.. (1999). Mutations in Exon 3 of the PAH Gene Causing Mild Hyperphenylalaninemia. Genetic Testing. 3(3). 297–299. 2 indexed citations
18.
Ciechanowski, Kazimierz, et al.. (1999). Chlorpropamide Toxicity with Survival Despite 27-Day Hypoglycemia. Journal of Toxicology Clinical Toxicology. 37(7). 869–871. 9 indexed citations
19.
Żekanowski, Cezary, et al.. (1998). Identification of mutations causing 6-pyruvoyl-tetrahydrobiopterin synthase deficiency in polish patients with variant hyperphenylalaninemia*. Molecular Diagnosis. 3(4). 237–239. 6 indexed citations
20.
Żekanowski, Cezary, et al.. (1994). Frequencies of the most common mutations responsible for phenylketonuria in Poland. Molecular and Cellular Probes. 8(4). 323–324. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026